Dear Doctor - Participate in the Survey on metoprolol " A new survey has found that the vast majority of people who take the blood pressure medication metoprolol are satisfied with the results. The survey, which was conducted by Consumer Reports, polled more than 1,000 people who were taking metoprolol and found that 92% were satisfied with the drug.Metoprolol is a beta-blocker that is typically used to treat hypertension, or high blood pressure. It works by blocking the action of certain hormones in the body that can raise blood pressure. Beta-blockers are some of the most commonly prescribed medications for hypertension, and metoprolol is one of the most popular choices.The Consumer Reports survey found that people who took metoprolol felt it was effective in lowering their blood pressure and reducing their risk of heart attack or stroke. They also reported few side effects from the drug. The most common side effect reported was fatigue, but only 10% of those surveyed said it was a problem for them.Overall, the survey found that metoprolol is an effective and well-tolerated medication for hypertension. If you are taking metoprolol or considering starting on this medication, be sure to speak to your doctor about your specific situation to see if it is right for you. Participate in Surveys "
1.
Video: Liver transplant for patients with advanced colorectal cancer
2.
La interacción GBP3-STING en el glioblastoma coordina la respuesta deficiente al temozolomide.
3.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
4.
AI is useful in low-resource areas for triaging breast masses.
5.
Does pollution cause cancer?
1.
Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review
2.
Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine
3.
Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense
4.
Unlocking the Potential of Onivyde: A New Hope for Cancer Treatment
5.
Beyond the Cure: The Emerging Role of Tissue-Agnostic Therapies in Palliative Oncology
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
4.
Navigating the Complexities of Ph Negative ALL - Part VII
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation